ArticleMolecular neurobiology2025
Dual Effect of Melatonin in Fetal Brain: Structural and Cellular Implications in a Rabbit Model of Intrauterine Growth Restriction.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Delineating the effects of prenatal oxycodone exposure and melatonin treatment on placental and fetal outcomes in pregnant rats.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrauterine growth restriction (IUGR) is a condition in which the fetus fails to reach its genetic growth potential, often resulting in neurodevelopmental alterations. This study investigates the neuroprotective potential of gestational melatonin (MEL) treatment using an IUGR rabbit model. IUGR was induced by ligating the uteroplacental vessels of one uterine horn in pregnant rabbits, using the other horn as the control (CNT). Dams received either placebo (PLA) or MEL from gestational day 25 to 30, when pups were delivered by cesarean section. We performed a functional evaluation, followed by placental histopathology, oligodendrocyte quantification, neuronal arborization, and DAB (3, 3'-diaminobenzidine) staining of MEL receptors in the brain. IUGR groups exhibited significantly lower body weights and survival rates than CNTs, confirming successful model induction. Placental analysis indicated higher phase 2 ischemia in IUGR than CNTs, and reduced calcifications in MEL-treated groups. Brain analysis showed fewer oligodendrocytes and MEL receptors in PLA-treated IUGR groups compared to CNTs, partially reversed by MEL treatment. A dual response to MEL was observed in several endpoints, with beneficial effects on IUGR and detrimental effects on CNT groups. In conclusion, MEL demonstrates beneficial effects on the IUGR brain, particularly by increasing oligodendrocyte numbers, but its detrimental effects in CNT groups warrant caution in healthy pregnancies. These results indicate that substances can act as both therapeutic and toxic agents depending on physiological context, underscoring the need for further research to understand MEL's mechanisms and optimize treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.